There is a lack of guidelines regarding the selection of patients who need intravenous heparin, duration of intravenous heparin, and future use of warfarin in prevention and treatment of warfarin-induced skin necrosis. This case report emphasizes the challenges in dealing with vitamin K antagonists (VKA) therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SMJ.0b013e3181c47dcf | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!